Literature DB >> 14594890

Quantification of regional left ventricular function in Q wave and non-Q wave dysfunctional regions by tissue Doppler imaging in patients with ischaemic cardiomyopathy.

M Bountioukos1, A F L Schinkel, J J Bax, V Rizzello, R Rambaldi, E C Vourvouri, J R T C Roelandt, D Poldermans.   

Abstract

OBJECTIVE: To quantify regional left ventricular (LV) function and contractile reserve in Q wave and non-Q wave regions in patients with previous myocardial infarction.
DESIGN: An observational study.
SETTING: Tertiary care centre. PATIENTS: 81 patients with previous myocardial infarction and depressed LV function.
INTERVENTIONS: All patients underwent surface ECG at rest and pulsed wave tissue Doppler imaging at rest and during low dose dobutamine infusion. The left ventricle was divided into four major regions (anterior, inferoposterior, septal, and lateral). Severely hypokinetic, akinetic, and dyskinetic regions on two dimensional echocardiography at rest were considered dysfunctional. MAIN OUTCOME MEASURES: Regional myocardial systolic velocity (Vs) at rest and the change in Vs during low dose dobutamine infusion (DeltaVs) in dysfunctional regions with and without Q waves on surface ECG.
RESULTS: 220 (69%) regions were dysfunctional; 60 of these regions corresponded to Q waves and 160 were not related to Q waves. Vs and DeltaVs were lower in dysfunctional than in non-dysfunctional regions (mean (SD) Vs 6.2 (1.9) cm/s v 7.1 (1.7) cm/s (p < 0.001), and DeltaVs 1.9 (1.9) cm/s v 2.6 (2.5) cm/s (p = 0.009), respectively). There were no significant differences in Vs and DeltaVs among dysfunctional regions with and without Q waves (Q wave regions: Vs 6.2 (1.8) cm/s, DeltaVs 1.6 (2.2) cm/s; non-Q wave regions: Vs 6.3 (1.9) cm/s, DeltaVs 2.0 (2.0) cm/s).
CONCLUSIONS: Quantitative pulsed wave tissue Doppler demonstrated that, among dysfunctional regions, Q waves on the ECG do not indicate more severe dysfunction, and myocardial contractile reserve is comparable in Q wave and non-Q wave dysfunctional myocardium.

Entities:  

Mesh:

Year:  2003        PMID: 14594890      PMCID: PMC1767948          DOI: 10.1136/heart.89.11.1322

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.

Authors:  R Rambaldi; D Poldermans; J J Bax; E Boersma; A Elhendy; W Vletter; J R Roelandt; R Valkema
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

2.  Myocardial Doppler velocity imaging--a quantitative technique for interpretation of dobutamine echocardiography.

Authors:  E Yamada; M Garcia; J D Thomas; T H Marwick
Journal:  Am J Cardiol       Date:  1998-09-15       Impact factor: 2.778

3.  Quantitative evaluation of the segmental left ventricular response to dobutamine stress by tissue Doppler echocardiography.

Authors:  W E Katz; V K Gulati; C M Mahler; J Gorcsan
Journal:  Am J Cardiol       Date:  1997-04-15       Impact factor: 2.778

4.  Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy.

Authors:  J H Cornel; J J Bax; A Elhendy; A P Maat; G J Kimman; M L Geleijnse; R Rambaldi; E Boersma; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

5.  Sensitivity of a set of myocardial infarction screening criteria in patients with anatomically documented single and multiple infarcts.

Authors:  D C Sevilla; N B Wagner; W D Anderson; R E Ideker; K A Reimer; E M Mikat; D B Hackel; R H Selvester; G S Wagner
Journal:  Am J Cardiol       Date:  1990-10-01       Impact factor: 2.778

6.  Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.

Authors:  K S Lee; T H Marwick; S A Cook; R T Go; J S Fix; K B James; S K Sapp; W J MacIntyre; J D Thomas
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

7.  Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.

Authors:  J J Bax; D Poldermans; A Elhendy; J H Cornel; E Boersma; R Rambaldi; J R Roelandt; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

8.  Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery.

Authors:  R Sciagrà; G Bisi; G M Santoro; F Zerauschek; S Sestini; P Pedenovi; R Pappagallo; P F Fazzini
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

9.  Correlation of electrocardiologic and pathologic findings in 100 cases of Q wave and non-Q wave myocardial infarction.

Authors:  Z Antalóczy; J Barcsák; E Magyar
Journal:  J Electrocardiol       Date:  1988-11       Impact factor: 1.438

10.  Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography.

Authors:  J J Bax; J H Cornel; F C Visser; P M Fioretti; A van Lingen; J M Huitink; O Kamp; F Nijland; J R Roelandt; C A Visser
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.